Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2003
03/13/2003US20030050333 Improved bioavailability; anticarcinogenic
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050318 Stable water in oil aminophylline emulsions
03/13/2003US20030050292 Applying a hydroalcoholic gel that comprises testosterone to the skin of a male
03/13/2003US20030050262 Inhibition of neurodegeneration
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050255 An ophthalmic formulation containing an ascomycin and at least one polymer selected from ethylene oxide-propylene oxide copolymer and a crosslinked acrylic acid polymer
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050238 Stable composition comprising epidermal growth factor as an active ingredient
03/13/2003US20030050228 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes
03/13/2003US20030050227 Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
03/13/2003US20030050226 Dopamine analog amide
03/13/2003US20030049721 Glycoconjugates and methods
03/13/2003US20030049689 Generation of polypeptide for use in the treatment of injuries, infections and cancer; obtain library of peptides, join to generate polypeptide, evaluate activity of polypeptide
03/13/2003US20030049672 Modulation of protein binding; obtain sample containing polypeptides, incubate with modulator, detect adjustment in protein activity
03/13/2003US20030049605 Display of viral proteins
03/13/2003US20030049440 Containing acrylate ester copolymer, organometallic compound and polyol
03/13/2003US20030049328 Porous beta-tricalcium phosphate granules and methods for producing same
03/13/2003US20030049327 Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
03/13/2003US20030049325 Compressed nontoxic carrier; sponge expansion in stomach; sustained release
03/13/2003US20030049322 Aqueous-based pharmaceutical composition
03/13/2003US20030049320 Novel in-situ forming controlled release microcarrier delivery system
03/13/2003US20030049318 Sustained release formulations of guaifenesin and additional drug ingredients
03/13/2003US20030049316 Mixture containing carbohydrate and binder
03/13/2003US20030049315 Blending wih starch, lubricant, wetting agent; compression
03/13/2003US20030049311 Pharmaceutical formulation
03/13/2003US20030049309 Veterinary compositions for the treatment of parasitic diseases
03/13/2003US20030049308 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication
03/13/2003US20030049302 Anticancer agent in intravagina device
03/13/2003US20030049289 Cosmetic or dermatological preparations of the oil-in-water type
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049280 Spontaneous emulsions containing cyclosporine
03/13/2003US20030049279 Polysaccharide encapsualted antigen
03/13/2003US20030049264 Releasing neurotransmitters; analgesics
03/13/2003US20030049262 Methods for identification, diagnosis, and treatment of breast cancer
03/13/2003US20030049253 Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines
03/13/2003US20030049247 Pharmaceutical composition comprising carriers for products based on vitamin-e, pa pain and hyaluronidase
03/13/2003US20030049245 Methods for sterilizing preparations of digestive enzymes
03/13/2003US20030049242 Decorated red blood cells
03/13/2003US20030049208 For delivering a medicant; product includes a coating having a medicament or agent; bioavailabilty; chewing gum product that releases caffiene for improved performance
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003US20030049158 Stablization and terminal sterilization of phospholipid formulations
03/13/2003CA2833997A1 Method and apparatus for nitric oxide generation
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2459413A1 Methods for sterilizing preparations containing albumin
03/13/2003CA2458995A1 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003CA2458963A1 Increased solubility flavanolignan preparations
03/13/2003CA2458799A1 Treatment for central nervous system disorders
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003CA2458613A1 Light-stabilized in vivo stain composition and method of manufacture
03/13/2003CA2457926A1 Pharmaceutical compositions for the treatment of asthma
03/13/2003CA2457526A1 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
03/13/2003CA2457520A1 Modified transferrin fusion proteins
03/13/2003CA2456904A1 Aerosolized decongestants for the treatment of sinusitis
03/13/2003CA2429345A1 Conjugates of a therapeutic agent and a peptide carrier
03/12/2003EP1291025A2 Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption
03/12/2003EP1291021A2 Pharmaceutical formulations for thyroid hormones
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1291014A1 A process for producing a pharmaceutical solid preparation containing a poorly soluble drug
03/12/2003EP1291013A2 Storage-stable pharmaceutical compositions
03/12/2003EP1290230A2 Hepatitis c virus conjugates
03/12/2003EP1290153A2 Molecular delivery vehicle for delivery of selected compounds to targets
03/12/2003EP1290027A2 Immunoadhesin for the prevention of rhinovirus infection
03/12/2003EP1290017A2 Compositions and methods for delivery of a molecule into a cell
03/12/2003EP1289645A2 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
03/12/2003EP1289642A1 Nanocapsules having a polyelectrolyte envelope
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof
03/12/2003EP1289568A2 Combination product for carrying out a cytotoxic treatment in a mammal
03/12/2003EP1289567A2 Lyophilizable and enhanced compacted nucleic acids
03/12/2003EP1289565A2 Compounds for targeting endothelial cells
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289563A2 Biotin derivatives
03/12/2003EP1289562A2 Novel of preparation hypericin bonded with poly-n-vinylamides
03/12/2003EP1289560A1 Novel solid dispersion compositions
03/12/2003EP1289556A2 Phytoestrogenic isoflavone compositions
03/12/2003EP1289543A2 Formulations and methods for treating hypercoagulable states
03/12/2003EP1289539A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289532A2 Low carbohydrate compositions, kits thereof, and methods of use
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289529A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
03/12/2003EP1289528A1 Active substance combination containing an opioid having a fentanyl-type structure and ketamine
03/12/2003EP1289524A2 Porous celecoxib matrices and methods of manufacture thereof
03/12/2003EP1289518A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
03/12/2003EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives
03/12/2003EP1289516A1 Composition for pain mediation and apparatus and method of use thereof
03/12/2003EP1289515A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof
03/12/2003EP1289506A1 Novel composition
03/12/2003EP1289505A1 Novel process
03/12/2003EP1289504A2 Neurotoxin implant
03/12/2003EP1289503A2 O/w emulsion
03/12/2003EP1289502A1 Microemulsion preconcentrates, microemulsion and use of such a composition
03/12/2003EP1289501A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289500A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289499A1 Pharmaceutical anti-inflammatory aerosol formulation
03/12/2003EP1289498A1 Novel pharmaceutical formulation suitable for nebulisation
03/12/2003EP1289497A1 Novel aqueous anti-inflammatory pharmaceutical formulation
03/12/2003EP1289496A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 1712